Alaunos Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Accrued Liabilities of -$68.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$63.00K, a 280.00% decline year-over-year.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$5.00K, a 109.09% decline year-over-year.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $122.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$188.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $24.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.16M.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$3.99M.
- Alaunos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$668.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 85 month | Increase (Decrease) in Accrued Liabilities 94 month | Increase (Decrease) in Accrued Liabilities 97 month | Increase (Decrease) in Accrued Liabilities 100 month | Increase (Decrease) in Accrued Liabilities 103 month | Increase (Decrease) in Accrued Liabilities 106 month | Increase (Decrease) in Accrued Liabilities 109 month | Increase (Decrease) in Accrued Liabilities 112 month | Increase (Decrease) in Accrued Liabilities 115 month | Increase (Decrease) in Accrued Liabilities 118 month | Increase (Decrease) in Accrued Liabilities 121 month | Increase (Decrease) in Accrued Liabilities 124 month | Increase (Decrease) in Accrued Liabilities 127 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$68.00K 10-Q · filed 2026-08-14 | $54.00K derived: sum of 3 quarters · filed 2026-08-14 | -$134.00K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-15 | $117.00K derived: sum of 2 quarters · filed 2026-05-15 | -$71.00K derived: sum of 3 quarters · filed 2026-05-15 | -$36.00K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$66.00K derived: sum of 2 quarters · filed 2026-03-31 | -$31.00K derived: sum of 3 quarters · filed 2026-08-14 | $24.00K 10-K · filed 2026-03-31 | |||||||||||||
| 2025-09-30 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$153.00K derived: sum of 2 quarters · filed 2026-08-14 | -$98.00K 10-Q · filed 2025-11-14 | -$290.00K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $90.00K 10-Q · filed 2026-08-14 | -$102.00K derived: sum of 3 quarters · filed 2026-08-14 | -$276.00K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-03-31 | $55.00K 10-Q · filed 2026-05-15 | -$137.00K derived: sum of 2 quarters · filed 2026-05-15 | -$311.00K derived: sum of 3 quarters · filed 2026-05-15 | -$412.00K derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||||
| 2024-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$366.00K derived: sum of 2 quarters · filed 2026-03-31 | -$467.00K derived: sum of 3 quarters · filed 2026-03-31 | -$1.16M 10-K · filed 2026-03-31 | |||||||||||||
| 2024-09-30 | -$174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$275.00K derived: sum of 2 quarters · filed 2025-11-14 | -$972.00K 10-Q · filed 2025-11-14 | -$2.70M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||
| 2024-06-30 | -$101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$798.00K 10-Q · filed 2025-08-14 | -$2.53M derived: sum of 3 quarters · filed 2025-08-14 | -$2.69M derived: sum of 4 quarters · filed 2025-08-14 | |||||||||||||
| 2024-03-31 | -$697.00K 10-Q · filed 2025-05-15 | -$2.43M derived: sum of 2 quarters · filed 2025-05-15 | -$2.59M derived: sum of 3 quarters · filed 2025-05-15 | -$3.35M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||
| 2023-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.89M derived: sum of 2 quarters · filed 2025-03-31 | -$2.65M derived: sum of 3 quarters · filed 2025-03-31 | -$3.99M 10-K · filed 2025-03-31 | |||||||||||||
| 2023-09-30 | -$163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$924.00K derived: sum of 2 quarters · filed 2024-11-14 | -$2.26M 10-Q · filed 2024-11-14 | -$4.45M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||
| 2023-06-30 | -$761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.10M 10-Q · filed 2024-08-14 | -$4.29M derived: sum of 3 quarters · filed 2024-08-14 | -$2.40M derived: sum of 4 quarters · filed 2024-08-14 | |||||||||||||
| 2023-03-31 | -$1.33M 10-Q · filed 2024-05-15 | -$3.53M derived: sum of 2 quarters · filed 2024-05-15 | -$1.63M derived: sum of 3 quarters · filed 2024-05-15 | -$1.79M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||
| 2022-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$300.00K derived: sum of 2 quarters · filed 2024-04-01 | -$454.00K derived: sum of 3 quarters · filed 2024-04-01 | -$668.00K 10-K · filed 2024-04-01 | |||||||||||||
| 2022-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.74M derived: sum of 2 quarters · filed 2023-11-14 | $1.52M 10-Q · filed 2023-11-14 | -$5.82M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||
| 2022-06-30 | -$154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$368.00K 10-Q · filed 2023-08-14 | -$7.71M derived: sum of 3 quarters · filed 2023-08-14 | -$6.14M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||
| 2022-03-31 | -$214.00K 10-Q · filed 2023-05-10 | -$7.56M derived: sum of 2 quarters · filed 2023-05-10 | -$5.98M derived: sum of 3 quarters · filed 2023-05-10 | -$8.04M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||
| 2021-12-31 | -$7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$5.77M derived: sum of 2 quarters · filed 2023-03-07 | -$7.83M derived: sum of 3 quarters · filed 2023-03-07 | -$10.51M 10-K · filed 2023-03-07 | |||||||||||||
| 2021-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$485.00K derived: sum of 2 quarters · filed 2022-11-14 | -$3.17M 10-Q · filed 2022-11-14 | -$1.73M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||
| 2021-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$4.74M 10-Q · filed 2022-08-15 | -$3.30M derived: sum of 3 quarters · filed 2022-08-15 | -$2.79M derived: sum of 4 quarters · filed 2022-08-15 | |||||||||||||
| 2021-03-31 | -$2.68M 10-Q · filed 2022-05-16 | -$1.24M derived: sum of 2 quarters · filed 2022-05-16 | -$732.00K derived: sum of 3 quarters · filed 2022-05-16 | $382.00K derived: sum of 4 quarters · filed 2022-05-16 | |||||||||||||
| 2020-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.95M derived: sum of 2 quarters · filed 2022-03-30 | $3.07M derived: sum of 3 quarters · filed 2022-03-30 | $5.27M 10-K · filed 2022-03-30 | |||||||||||||
| 2020-09-30 | $508.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.62M derived: sum of 2 quarters · filed 2021-11-08 | $3.83M 10-Q · filed 2021-11-08 | $4.74M derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||||
| 2020-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $3.32M 10-Q · filed 2021-08-13 | $4.24M derived: sum of 3 quarters · filed 2021-08-13 | $5.01M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||||||
| 2020-03-31 | $2.21M 10-Q · filed 2021-05-06 | $3.12M derived: sum of 2 quarters · filed 2021-05-06 | $3.90M derived: sum of 3 quarters · filed 2021-05-06 | $5.86M derived: sum of 4 quarters · filed 2021-05-06 | |||||||||||||
| 2019-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.69M derived: sum of 2 quarters · filed 2021-03-01 | $3.65M derived: sum of 3 quarters · filed 2021-03-01 | $1.73M 10-K · filed 2021-03-01 | |||||||||||||
| 2019-09-30 | $774.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.74M derived: sum of 2 quarters · filed 2020-11-05 | $810.00K 10-Q · filed 2020-11-05 | $197.00K derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2019-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $36.00K 10-Q · filed 2020-08-06 | -$577.00K derived: sum of 3 quarters · filed 2021-03-01 | $136.00K derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2019-03-31 | -$1.93M 10-Q · filed 2020-05-07 | -$2.54M derived: sum of 2 quarters · filed 2021-03-01 | -$1.83M derived: sum of 3 quarters · filed 2021-03-01 | -$2.04M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2018-12-31 | -$613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $100.00K derived: sum of 2 quarters · filed 2021-03-01 | -$115.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.15M 10-K · filed 2021-03-01 | |||||||||||||
| 2018-09-30 | $713.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $498.00K derived: sum of 2 quarters · filed 2019-11-07 | -$532.00K 10-Q · filed 2019-11-07 | -$734.00K derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||
| 2018-06-30 | -$215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$1.25M 10-Q · filed 2019-08-08 | -$1.45M derived: sum of 3 quarters · filed 2020-03-02 | -$691.00K derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||
| 2018-03-31 | -$1.03M 10-Q · filed 2019-05-08 | -$1.23M derived: sum of 2 quarters · filed 2020-03-02 | -$476.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.81M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||
| 2017-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $554.00K derived: sum of 2 quarters · filed 2020-03-02 | -$777.00K derived: sum of 3 quarters · filed 2020-03-02 | $800.00K 10-K · filed 2020-03-02 | |||||||||||||
| 2017-09-30 | $756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$575.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.00M 10-Q · filed 2018-11-09 | $2.75M derived: sum of 4 quarters · filed 2019-03-05 | |||||||||||||
| 2017-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $246.00K 10-Q · filed 2018-08-08 | $1.99M derived: sum of 3 quarters · filed 2019-03-05 | $1.96M derived: sum of 4 quarters · filed 2019-03-05 | |||||||||||||
| 2017-03-31 | $1.58M 10-Q · filed 2018-05-10 | $3.32M derived: sum of 2 quarters · filed 2019-03-05 | $3.29M derived: sum of 3 quarters · filed 2019-03-05 | $2.10M derived: sum of 4 quarters · filed 2019-03-05 | |||||||||||||
| 2016-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $1.72M derived: sum of 2 quarters · filed 2019-03-05 | $527.00K derived: sum of 3 quarters · filed 2019-03-05 | $203.00K 10-K · filed 2019-03-05 | |||||||||||||
| 2016-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$1.22M derived: sum of 2 quarters · filed 2017-11-06 | -$1.54M 10-Q · filed 2017-11-06 | -$10.77M derived: sum of 4 quarters · filed 2018-03-01 | |||||||||||||
| 2016-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$1.51M 10-Q · filed 2017-07-31 | -$10.74M derived: sum of 3 quarters · filed 2018-03-01 | -$1.36M derived: sum of 4 quarters · filed 2018-03-01 | |||||||||||||
| 2016-03-31 | -$324.00K 10-Q · filed 2017-05-01 | -$9.56M derived: sum of 2 quarters · filed 2018-03-01 | -$169.00K derived: sum of 3 quarters · filed 2018-03-01 | $363.00K derived: sum of 4 quarters · filed 2018-03-01 | |||||||||||||
| 2015-12-31 | -$9.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $155.00K derived: sum of 2 quarters · filed 2018-03-01 | $687.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.72M 10-K · filed 2018-03-01 | |||||||||||||
| 2015-09-30 | $9.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $9.92M derived: sum of 2 quarters · filed 2016-11-09 | $10.96M 10-Q · filed 2016-11-09 | $10.34M derived: sum of 4 quarters · filed 2017-02-16 | |||||||||||||
| 2015-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.57M 10-Q · filed 2016-08-09 | $949.00K derived: sum of 3 quarters · filed 2017-02-16 | $980.00K derived: sum of 4 quarters · filed 2017-02-16 | |||||||||||||
| 2015-03-31 | $1.04M 10-Q · filed 2016-05-10 | $417.00K derived: sum of 2 quarters · filed 2017-02-16 | $448.00K derived: sum of 3 quarters · filed 2017-02-16 | $2.47M derived: sum of 4 quarters · filed 2017-02-16 | |||||||||||||
| 2014-12-31 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$589.00K derived: sum of 2 quarters · filed 2017-02-16 | $1.43M derived: sum of 3 quarters · filed 2017-02-16 | $827.00K 10-K · filed 2017-02-16 | |||||||||||||
| 2014-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $2.05M derived: sum of 2 quarters · filed 2015-11-02 | $1.45M 10-Q · filed 2015-11-02 | -$3.77M derived: sum of 4 quarters · filed 2016-02-24 | |||||||||||||
| 2014-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.42M 10-Q · filed 2015-08-10 | -$3.80M derived: sum of 3 quarters · filed 2016-02-24 | -$11.20M derived: sum of 4 quarters · filed 2016-02-24 | |||||||||||||
| 2014-03-31 | -$605.00K 10-Q · filed 2015-05-07 | -$5.82M derived: sum of 2 quarters · filed 2016-02-24 | -$13.22M derived: sum of 3 quarters · filed 2016-02-24 | -$12.77M derived: sum of 4 quarters · filed 2016-02-24 | $5.75M 10-Q · filed 2014-05-08 | ||||||||||||
| 2013-12-31 | -$5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$12.61M derived: sum of 2 quarters · filed 2016-02-24 | -$12.16M derived: sum of 3 quarters · filed 2016-02-24 | -$10.16M 10-K · filed 2016-02-24 | $6.36M 10-K · filed 2014-03-03 | ||||||||||||
| 2013-09-30 | -$7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$6.95M derived: sum of 2 quarters · filed 2014-10-30 | -$4.94M 10-Q · filed 2014-10-30 | -$5.11M derived: sum of 4 quarters · filed 2015-02-26 | $11.57M 10-Q · filed 2013-10-22 | ||||||||||||
| 2013-06-30 | $448.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.45M 10-Q · filed 2014-08-07 | $2.29M derived: sum of 3 quarters · filed 2015-02-26 | $3.47M derived: sum of 4 quarters · filed 2015-02-26 | $18.97M 10-Q · filed 2013-08-08 | ||||||||||||
| 2013-03-31 | $2.00M 10-Q · filed 2014-05-08 | $1.84M derived: sum of 2 quarters · filed 2015-02-26 | $3.02M derived: sum of 3 quarters · filed 2015-02-26 | $6.99M derived: sum of 4 quarters · filed 2015-02-26 | $18.52M 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | -$166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.01M derived: sum of 2 quarters · filed 2015-02-26 | $4.98M derived: sum of 3 quarters · filed 2015-02-26 | $5.70M 10-K · filed 2015-02-26 | $16.52M 10-K · filed 2013-03-18 | ||||||||||||
| 2012-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $5.15M derived: sum of 2 quarters · filed 2013-10-22 | $5.86M 10-Q · filed 2013-10-22 | $7.89M derived: sum of 4 quarters · filed 2014-03-03 | $16.68M 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $4.68M 10-Q · filed 2013-08-08 | $6.71M derived: sum of 3 quarters · filed 2014-03-03 | $9.42M derived: sum of 4 quarters · filed 2014-03-03 | $15.50M 10-Q/A · filed 2012-08-28 | ||||||||||||
| 2012-03-31 | $713.00K 10-Q · filed 2013-05-07 | $2.75M derived: sum of 2 quarters · filed 2014-03-03 | $5.45M derived: sum of 3 quarters · filed 2014-03-03 | $7.67M derived: sum of 4 quarters · filed 2014-03-03 | $11.53M 10-Q · filed 2012-05-03 | ||||||||||||
| 2011-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $4.74M derived: sum of 2 quarters · filed 2014-03-03 | $6.96M derived: sum of 3 quarters · filed 2014-03-03 | $8.28M 10-K · filed 2014-03-03 | $10.82M 10-K · filed 2012-02-29 | ||||||||||||
| 2011-09-30 | $2.71M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | $4.93M derived: sum of 2 quarters · filed 2012-11-08 | $6.25M 10-Q · filed 2012-11-08 | $5.81M derived: sum of 4 quarters · filed 2013-03-18 | $8.79M 10-Q · filed 2011-11-03 | ||||||||||||
| 2011-06-30 | $2.22M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28 | $3.55M 10-Q/A · filed 2012-08-28 | $3.11M derived: sum of 3 quarters · filed 2013-03-18 | $4.95M derived: sum of 4 quarters · filed 2013-03-18 | $6.08M 10-Q/A · filed 2011-08-09 | ||||||||||||
| 2011-03-31 | $1.32M 10-Q · filed 2012-05-03 | $884.00K derived: sum of 2 quarters · filed 2013-03-18 | $2.72M derived: sum of 3 quarters · filed 2013-03-18 | ||||||||||||||
| 2010-12-31 | -$440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.40M derived: sum of 2 quarters · filed 2013-03-18 | $1.28M 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | $1.84M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-03 | $1.72M 10-Q · filed 2011-11-03 | $2.98M 10-Q · filed 2011-08-01 | ||||||||||||||
| 2010-06-30 | -$122.00K 10-Q/A · filed 2011-08-09 | ||||||||||||||||
| 2009-12-31 | -$648.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$1.88M 10-K · filed 2012-02-29 | |||||||||||||||
| 2009-09-30 | -$1.23M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |